Climb Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Climb Bio and other ETFs, options, and stocks.

About CLYM

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases.

CEO

Aoife M. Brennan

CEOAoife M. Brennan

Employees

Employees18

Headquarters

Wellesley Hills, Massachusetts

HeadquartersWellesley Hills, Massachusetts

Founded

2018

Founded2018

Employees

Employees18

CLYM Key Statistics

Market cap

84.81M

Market cap84.81M

Price-Earnings ratio

-0.53

Price-Earnings ratio-0.53

Dividend yield

—

Dividend yield—

Average volume

573.17K

Average volume573.17K

High today

$1.28

High today$1.28

Low today

$1.19

Low today$1.19

Open price

$1.19

Open price$1.19

Volume

171.10K

Volume171.10K

52 Week high

$9.21

52 Week high$9.21

52 Week low

$1.05

52 Week low$1.05

People also own

Based on the portfolios of people who own CLYM. This list is generated using Robinhood data, and it’s not a recommendation.